Bixiye
QP20-24 Provider Press: Q1 2024
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2024
Natiijooyinka Raadinta
Soo bandhiga 1201 - 1210 ee natiijooyinka 3688
Bixiye
QP21-24 Update for New to Market Medical Drugs: DONANEMAB
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2024
Bixiye
QP25-24 Appeal Submission Timeframe Alignment
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2024
Bixiye
QP26-24 Commercial Pharmacy Benefit Exclusion for Amtagvi®
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2024
Bixiye
QP27-24 MHCP Pharmacy Benefit Exclusion for Amtagvi® and Pemrydi RTU™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2024
Bixiye
QP13-24 Providers Must be Enrolled with DHS Prior to Submitting Contract Requests
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Bixiye
P6-24 Removing 99606 Visit Limitation for Medication Therapy Management (MTM) Services in the Medicaid Population Starting April 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2024
Bixiye
P7-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2024
Bixiye
P8-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2024
Bixiye
P16-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2024